HULC and hepatocellular carcinoma: Li et al. [101] found that in the plasma samples of HCC patients, HULC and LINC00152 were up-regulated in the plasma samples of HCC patients and that they have a high diagnostic value for the occurrence and metastasis of liver cancer, can be considered as a new biomarker for liver cancer.